Clinical Trial Update: Donepezil for Oxaliplatin-induced Neuropathy Peripheral Neuropathy: Proof of Concept Study [Phase 2]

View source ↗

Summary

Phase 2 proof-of-concept study evaluating donepezil for oxaliplatin-induced peripheral neuropathy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Digestive Oncology
• Supportive Care

Drugs mentioned

• Donepezil (donepezil)

Snippet

Sponsor: University Hospital, Clermont-Ferrand | Conditions: Digestive Oncology, Supportive Care | Phase 2 | Status: COMPLETED